FMP
Nov 17, 2025(Last modified: Nov 18, 2025)
Wizz Air Holdings PLC, listed as OTC:WZZZY, is a low-cost airline operating primarily in Central and Eastern Europe. The company is known for its budget-friendly flights and has been expanding its network across Europe. However, it faces competition from other low-cost carriers like Ryanair and EasyJet. Recently, Deutsche Bank maintained its "Hold" rating for WZZZY, with the stock priced at $3.80.
Deutsche Bank also adjusted its price target for Wizz Air from 1,400 GBp to 1,250 GBp. This change comes as Wizz Air is reducing its operations at Gatwick Airport due to high operating costs and poorly timed take-off slots. The airline is shifting its focus to Luton Airport, where costs are lower, and initially redeploying one aircraft to increase its Luton-based fleet to 13.
Despite Gatwick's near full capacity, which has increased fees and squeezed margins, Wizz Air is not abandoning the airport. Instead, it is adjusting its network to focus on more profitable bases. A new runway at Gatwick is under development but won't be operational until the 2030s. This strategic move aims to improve profitability by optimizing operational costs.
Wizz Air is also introducing a new "Wizz Class" option in December, offering extra space and priority services for an additional charge. This initiative could attract more passengers seeking comfort, potentially boosting revenue. The stock for WZZZY has fluctuated between a high of $7.00 and a low of $3.33 over the past year, with a current market capitalization of approximately $1.57 billion.
The trading volume for WZZZY is notably low, with only 100 shares exchanged. This low volume can impact the stock's liquidity, making it more susceptible to price volatility. As Wizz Air continues to adjust its operations and explore new revenue streams, investors will be watching closely to see how these changes affect the company's financial performance.
XPeng Inc. (NYSE:XPEV) is a prominent player in the electric vehicle (EV) market, known for its innovative approach to s...
Zymeworks Inc. (NASDAQ:ZYME) is a biotechnology company focused on developing multifunctional therapeutics, primarily fo...